Ovarian Cancer

WOMEN'S HEALTH 13m 37s 0.5 Credit CME Testing for Breast Cancer Susceptibility Genes JAMA

GYNECOLOGIC CANCER 1 Credit CME Association of Powder Use in the Genital Area With Risk of Ovarian Cancer JAMA

WOMEN'S HEALTH 12m 23s Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer JAMA Oncology

WOMEN'S HEALTH 32m 38s 0.5 Credit CME USPSTF Recommendation: Assessment, Counseling, and Testing for BRCA-Related Cancer JAMA

WOMEN'S HEALTH 2m 20s Tumor-Stroma Proportion as a Predictive Biomarker of Resistance to Platinum-Based Chemotherapy in Patients With Ovarian Cancer JAMA Oncology

GYNECOLOGIC CANCER 1 Credit CME Risk of Malignant Ovarian Cancer Based on Ultrasonography Findings in a Large Unselected Population JAMA Internal Medicine

WOMEN'S HEALTH 16m 20s Analgesic Use and Risk of Ovarian Cancer in the Nurses’ Health Studies JAMA Oncology

WOMEN'S HEALTH 7m 38s Outcomes of Multiple-Gene Sequencing After Diagnosis of Breast Cancer JAMA Oncology

GYNECOLOGY 1 Credit CME Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers JAMA Oncology

CLINICAL CHALLENGE 1 Credit CME Peristomal Nodule in a Patient With Ovarian Cancer JAMA

GYNECOLOGIC CANCER 1 Credit CME Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement JAMA

WOMEN'S HEALTH 19m 37s 0.5 Credit CME USPSTF Recommendation: Screening for Ovarian Cancer JAMA

WOMEN'S HEALTH 7m 42s Breast Cancer Due to Non– BRCA1 and Non– BRCA2 Mutations in Ashkenazi Jewish Women JAMA Oncology

WOMEN'S HEALTH 4m 38s BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer JAMA Oncology

WOMEN'S HEALTH 2m 19s BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer JAMA

WOMEN'S HEALTH Mechanism of Synthetic Lethality by PARP Inhibition in Cancer Cells With BRCA JAMA